Karki, K., Wright, G. A., Mohankumar, K., Jin, U., Zhang, X., & Safe, S. (2020). A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Anti-Tumor Immunity. Cancer Res.
シカゴスタイル引用形Karki, Keshav, Gus A. Wright, Kumaravel Mohankumar, Un-Ho Jin, Xing-Han Zhang, , Stephen Safe. "A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Anti-Tumor Immunity." Cancer Res 2020.
MLA引用形式Karki, Keshav, et al. "A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Anti-Tumor Immunity." Cancer Res 2020.
警告: この引用は必ずしも正確ではありません.